Zhuhai Yufan Biotechnology

Zhuhai Yufan Biotechnology is a biopharmaceutical company headquartered in Zhuhai, China, specializing in the discovery and development of next-generation small molecule therapeutics. The company utilizes an integrated drug discovery platform that combines high-throughput screening, structure-based drug design, and medicinal chemistry to target challenging biological pathways. Its primary therapeutic focus is oncology, with a pipeline featuring inhibitors for targets such as USP1 and KRAS. Yufan Biotechnology aims to address significant unmet medical needs through the development of highly selective and potent drug candidates.